药物对比
Rosiglitazone vs Lixisenatide
Rosiglitazone vs Lixisenatide：口服TZD vs 注射用GLP-1激动剂治疗2型糖尿病。比较疗效、心血管风险、给药方式及副作用。
此页面暂无可用的对比维度。
临床背景
This comparison is triggered when switching from older oral TZDs to modern GLP-1 agonists or evaluating oral versus injectable options in type 2 diabetes care.
结论
Lixisenatide generally offers a more favorable overall profile than Rosiglitazone for most patients, though individual factors determine suitability.
全部药物对比